Supporters and Exhibitors
The COGI Congress would like to thank the supporters. It is with the support of the industry that COGI can continue in its mission to promote research and education and to disseminate new knowledge
Click on the logo to find out more about the company!
IBSA has developed an entirely new purification process in order to obtain a full range of highly purified, human gonadotrophins (hFSH, hMG and hCG). This patented process ensures both a high level of purity and the full respect of the natural glycosylation of these molecules.
Recently IBSA has marketed a novel ingenious system to deliver progesterone subcutaneously in an aqueous solution.
IBSA has managed to guarantee the highest quality of its products over the years due to the advantages of having a complete in-house manufacturing process in company-owned plants and thanks to a global quality system.
The company’s other franchises include osteoarthritis, pain-management, dermatology and thyroid diseases.
For more information please visit www.ibsagroup.com
For more information please visit www.richter.hu
For more information please visit www.ferring.com
We have computerised systems that have been designed and worked on for over a decade, in order to ensure traceability and security. Furthermore, we are licensed according to the FDA and EU-Tissue Directive, setting the highest standards of quality and safety. For Cryos, it’s personal!
For more information about Cryos please visit dk.cryosinternational.com
With more than 50 years of experience, Fotona is a world-leading medical laser manufacturer recognized for its innovative, award-winning laser systems for applications in gynecology, surgery, aesthetics & dermatology and dentistry.
Fotona’s combined Er:YAG and Nd:YAG laser systems are proven to be less invasive and highly effective for clinical and aesthetic gynecology treatments. We are proud to be the first manufacturer to introduce SMOOTH® mode technology for a range of non-invasive laser vaginal treatments.
Our global distribution network spans across more than 90 countries, ensuring comprehensive support and service for Fotona laser users, including clinical training, workshops and hands-on demonstrations.
For more information about Fotona please visit www.fotona.com
For more information about Karl Storz please visit www.karlstorz.com
Founded in Florence (Italy) in 2012, the School, inspired by the values of scientific culture, ethics and bioethics of life sciences, pursues the aim of promoting and enhancing the fundamental ideals of maternal infant medicine in its entire course: reproductive, periconceptional, maternal and child health periods. The School run courses of reproductive, perinatal and neonatal medicine and related disciplines, training programs, national and international conferences, congresses, debates, and any other event or action consistent with its objectives.
For more information about Preis School please visit www.preischool.com
For more information about Besins please visit www.besinshealthcare.co.uk
Janssen Pharmaceutica NV is one of the Janssen Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity and healing hopelessness with heart.
We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension
For more information about Janssen please visit www.janssen.com/
Pantarhei Bioscience (PRB) and Pantarhei Oncology (PRO)
focus on innovative drug development in respectively Woman’s Health
(WH) and Reproductive Endocrine Oncology (REO) based on the ability to identify, confirm and patent protect novel targets and
medical uses of existing hormones, biologicals, drugs and combinations thereof with a focus on clinical development and human safety.
Pantarhei adheres to the highest scientific standards for preclinical and clinical drug development and aims at publication of results in
Major projects in the current Pantarhei pipelines include (i) Androgen Restored Contraception (ARC) to prevent the consequences of the
loss of testosterone caused by combined oral contraceptives (COCs) by adding dehydroepiandrosterone (DHEA) to COCs, (ii) the natural
fetal estrogen Estetrol (E4) for the (co)-treatment of advanced breast and prostate cancer and (iii) the use of the Zona Pellucida 3 (ZP3)
cancer antigen for immunotherapy of ZP3 expressing tumours such as ovarian, prostate, breast, colon and non-small-cell lung cancer
Pantarhei Bioscience / Pantarhei Oncology
Boulevard 17, 3707 BK Zeist, the Netherlands